Its stock has done well of late, but Scotia analyst Kevin Krishnaratne thinks there is still money t... Read More
Canadian software name Dye & Durham (Dye & Durham Stock Quote, Charts, News, Analysts, Finan... Read More
Canadian software company Dye & Durham (Dye & Durham Stock Quote, Charts, News, Analysts, Fi... Read More
It’s been months now since management announced its intentions to take the company private but the... Read More
Investors looking at Cipher Pharmaceuticals (Cipher Pharmaceuticals Stock Quote, Chart, News: TSX:DN... Read More
Robust M&A activity drove overall sector valuations in fiscal 2013, and we believe expectations ... Read More
Byron Capital analyst Douglas Loe says the price Canadian pharma giant Valeant Pharmaceutical... Read More
2012 was a good year for Cipher Pharmaceuticals (TSX:DND) The specialty pharma, which boasts three c... Read More
Investors haven’t been crying over the performance of TearLab, shares of the company are up mo... Read More
Shares of Cipher Pharmaceuticals (TSX:DND) are pulling back today, but investor interest in the comp... Read More
Risk is relative. In the middle part of the last-decade, when income trusts were all the rage, Missi... Read More
Pivotal Therapeutics (CSNX:PVO) announced it has filed five international patent applications relate... Read More
Another year, and another year of mining stock successes on the Toronto Stock Exchange. It seems lik... Read More
2010: The Top 20 Canadian Techs (So far) This Year 2009 was a year of recovery for the worldwide mar... Read More
Share
Tweet
pin
Share